Evidence map›Paper›PMID 37993756›Full record

ArticleImmunologic research2024

Insights into the immunological description of cryoglobulins with regard to detection and characterization in Slovenian rheumatological patients.

Manca Ogrič, Tinka Švec, Katjuša Mrak Poljšak, Katja Lakota, Eva Podovšovnik, Marie Nathalie Kolopp-Sarda, Alojzija Hočevar, Saša Čučnik

Open access · hybridAbstract read
In one paragraph

Article in Immunologic research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Manca OgričDepartment of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Tinka ŠvecDepartment of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Katjuša Mrak PoljšakDepartment of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Katja LakotaDepartment of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Eva PodovšovnikValdoltra Orthopaedic Hospital, Ankaran, Slovenia.
Marie Nathalie Kolopp-SardaImmunogenomics and Inflammation Research, University of Lyon, Lyon, France.
Alojzija HočevarDepartment of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Saša ČučnikDepartment of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia. sasa.cucnik@kclj.si.
Ljubljana University Medical Centre · SIOrthopaedic Hospital Valdoltra · SIUniversité Claude Bernard Lyon 1 · FRUniversity of Primorska · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The detection of cryoglobulins (CG) used to diagnose cryoglobulinemic vasculitis requires strict adherence to protocol, with emphasis on the preanalytical part. Our main objectives were to introduce a more sensitive and specific protocol for the detection of CG and to characterize CG in Slovenian patients diagnosed with cryoglobulinemic vasculitis, other vasculitides, connective tissue diseases or non-rheumatic diseases examined at the Department of Rheumatology (University Medical Centre Ljubljana). Samples were routinely analyzed for the presence of CG with the protocol using the Folin-Ciocalteu reagent. In the newly introduced protocol, the type of CG was determined by immunofixation on visually observed positive samples and the concentration of CG in the cryoprecipitate and rheumatoid factor (RF) activity were measured by nephelometry. RF, C3c and C4 were measured in patients` serum and a decision tree analysis was performed using all results. The agreement between negative and positive results between the two protocols was 86%. Of the 258 patient samples tested, we found 56 patients (21.7%) with positive CG (37.5% - type II, 62.5% - type III). The RF activity was observed in 21.4% of CG positive subjects. The median concentration of type II CG was significantly higher than that of type III CG (67.4 mg/L vs. 45.0 mg/L, p = 0.037). Patients with type II had lower C4 concentrations and higher RF compared to patients with type III CG. In the decision tree, C4 was the strongest predictor of cryoglobulinemia in patients. With the newly implemented protocol, we were able to improve the detection and quantification of CG in the samples of our rheumatology patients and report the results to adequately support clinicians.

Indexed as

CryoglobulinemiaRheumatic DiseasesRheumatologyVasculitisCryoglobulinsHumansRheumatoid FactorCryoglobulinsRheumatoid FactorComplement componentsCryoglobulin detectionCryoglobulinemic vasculitisCryoglobulinsPre-analytical phaseRheumatoid factor activity

Identifiers

PMID37993756
PMCPMC11031437
OpenAlexW4388923609

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.